Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;8(5):e312-e314.
doi: 10.1016/S2352-3026(21)00073-9. Epub 2021 Mar 31.

COVID-19 vaccines for patients with haematological conditions

Clare Sun  1 , Christopher Pleyer  2 , Adrian Wiestner  2
Affiliations

COVID-19 vaccines for patients with haematological conditions

Clare Sun et al. Lancet Haematol. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CS received research funding from Genmab. AW received research support from Pharmacyclics, an AbbVie company; Acerta Pharma, a member of the AstraZeneca group; Merck; Nurix; Verastem; and Genmab. CP declares no competing interests. The authors are supported by the Intramural Program of the National Heart, Lung and Blood Institute, National Institutes of Health.

References

    1. Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136:2881–2892. - PMC - PubMed
    1. Asch DA, Sheils NE, Islam MN, et al. Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic. JAMA Intern Med. 2020 https://doi:10.1001/jamainternmed.2020.8193 published online Dec 22. - DOI - PMC - PubMed
    1. Roeker LE, Knorr DA, Pessin MS, et al. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020;34:3047–3049. - PMC - PubMed
    1. Shah GL, DeWolf S, Lee YJ, et al. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation. J Clin Invest. 2020;130:6656–6667. - PMC - PubMed
    1. O'Nions J, Muir L, Zheng J, et al. SARS-CoV-2 antibody responses in patients with acute leukaemia. Leukemia. 2021;35:289–292. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources